News
Former Texas football star and NFL Hall of Famer Steve McMichael died Wednesday after a year-long battle with amyotrophic lateral sclerosis, or ALS. He was 67. McMichael entered hospice this week ...
The US Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, ...
The FDA has approved the first blood test for diagnosing Alzheimer’s disease, which could speed the path to treatment for ...
We recently published a list of 15 Small-Cap Healthcare Stocks Hedge Funds Are Buying. In this article, we are going to take ...
The global antisense oligonucleotides market is poised for remarkable growth over the next decade, projected to rise from USD 2,913.5 million in 2023 to USD 5,519.6 million by 2033 moving forward with ...
11d
Zacks Investment Research on MSNDenali Q1 Loss Wider Than Expected, Hunter Syndrome Drug in FocusDenali Therapeutics DNLI reported a first-quarter 2025 loss of 78 cents per share, wider than the Zacks Consensus Estimate of ...
Prilenia, Ferrer entered collaboration agreement for commercialization and co-development of pridopidine in Europe and other ...
Just four months after Eli Lilly and British biotech Alchemab penned a discovery collaboration, the Big Pharma is licensing ...
Biogen has ducked out of a four-year-old collaboration with Karyopharm on a drug candidate for the neurodegenerative disease amyotrophic lateral sclerosis that could have been worth up to $217 ...
While there’s no cure for ALS yet, several therapies approved by the U.S. Food and Drug Administration can help slow disease progression. A recent review in Frontiers of Neurology noted these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results